However, contradictory results were reported by Ma et al. who claimed no significant difference in hepcidin levels between different stages of breast cancer, suggesting that the correlation between hepcidin levels and cancer stage may not be straightforward, and could be influenced by other factors such as patient iron status, inflammation, and comorbidities [79]. The gene discussed is HAMP; the disease is breast carcinoma.